Recruiting

Brass Mesh Bolus

Sponsor:

Nova Scotia Cancer Centre

Code:

NCT05483712

Conditions

Breast Cancer

Eligibility Criteria

Sex: All

Age: 0+

Healthy Volunteers: Not accepted

Interventions

Brass Mesh Bolus

Study Details

Brief summary:

The hypothesis is that the daily use of brass mesh bolus achieves a comparable dose to every-other-day use of Superflab bolus (current standard of care) in chest wall post-mastectomy patients treated with rotational 6 MV photon delivery.

Conditions

Breast Cancer

Study ID

NCT05483712

Start date

Jan 18, 2023

Status verified date

May, 2024

Completion date

Nov 21, 2024

Anticipated

Primary completion date

Nov 21, 2024

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 0+

Healthy Volunteers: Not accepted

Inclusion Criteria:

Women undergoing rotational chest wall radiotherapy following mastectomy for breast cancer treatment who would utilize Superflab bolus on some, but not all, days of radiotherapy treatment.

Exclusion Criteria:

Patients who require daily bolus due to skin involvement or other high-risk features requiring a high skin dose will not be included.

Study Design

Enrollment

20 participants

Anticipated

Intervention Model

Single group

Primary purpose

Treatment

Interventions and Outcome Measures

Arms

experimental: Post-Mastectomy Radiation Therapy Patients

Any patient who is going through radiation to their chest wall following mastectomy using a rotational delivery technique and 6 MV, and uses Superflab bolus for some but not all fractions of radiotherapy

Interventions

Brass Mesh Bolus

During a standard-of-care 15 fraction radiotherapy treatment, a brass mesh bolus will be used for a single fraction. Small in-vivo dosimeters will be used for three treatment fractions to measure and compare skin doses for quantification purposes.

Primary outcome measure

  • Skin Dose Enhancement Under Brass Mesh Bolus [ Time Frame: through study completion, an average of 1 year ]

Central Contacts and Locations

Central contacts

Hannah Dahn, MD

902-473-6185Hannah.dahn@nshealth.ca

Locations

Nova Scotia Health Authority

Recruiting

Halifax, Nova Scotia, Canada, B3H 1V7

Contacts

Hannah Dahn, MD

902 473-6185Hannah.dahn@nshealth.ca

More Information

Sponsor

Nova Scotia Cancer Centre

Last update posted

May 22, 2024

Last verified

May, 2024

Keywords

  • Breast Cancer
  • Radiation Therapy
  • Brass Mesh
  • Bolus
  • Skin Dose

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Nova Scotia Cancer Centre on 2024-05-22.